The MTC in our case strongly expressed CA-IX while the presumed UBB remnants and C-cell hyperplasia showed no to weak expression according to IHC, perhaps giving credence to a RET-mediated activation despite no evidence of RET mutation according to ThyroSeq. The gene discussed is CA9; the disease is medullary thyroid gland carcinoma.